New vaccinia virus promoter as a potential candidate for future vaccines

Journal of General Virology

Volumn 94, Issue PART 12, 2013, Pages 2771-2776

  Di Pilato, Mauro ^a   Mejías Pérez, Ernesto ^a   Gómez, Carmen Elena ^a   Perdiguero, Beatriz ^a   Sorzano, Carlos Oscar S ^a   Esteban, Mariano ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GREEN FLUORESCENT PROTEIN; VACCINIA VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONSENSUS SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; VACCINATION; VACCINIA; VACCINIA VIRUS;

ANIMALS; BASE SEQUENCE; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DRUG DESIGN; GREEN FLUORESCENT PROTEINS; MICE; PROMOTER REGIONS, GENETIC; VACCINIA; VACCINIA VIRUS; VIRAL VACCINES;

EID: 84887550005     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.057299-0     Document Type: Article

References (24)

1. Assarsson, E., Greenbaum, J. A., Sundströ m, M., Schaffer, L., Hammond, J. A., Pasquetto, V., Oseroff, C., Hendrickson, R. C., Lefkowitz, E. J. & other authors (2008). Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes. Proc Natl Acad Sci U S A 105, 2140-2145.
2. Baur, K., Brinkmann, K., Schweneker, M., Pä tzold, J., Meisinger-Henschel, C., Hermann, J., Steigerwald, R., Chaplin, P., Suter, M. & Hausmann, J. (2010). Immediate-early expression of a recombinant antigen by modified vaccinia virus Ankara breaks the immunodominance of strong vector-specific B8R antigen in acute and memory CD8 T-cell responses. J Virol 84, 8743-8752.
3. Chakrabarti, S., Sisler, J. R. & Moss, B. (1997). Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 23, 1094-1097.
4. Gambotto, A., Dworacki, G., Cicinnati, V., Kenniston, T., Steitz, J., Tü ting, T., Robbins, P. D. & DeLeo, A. B. (2000). Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 7, 2036-2040.
5. García-Arriaza, J., Ná jera, J. L., Gómez, C. E., Sorzano, C. O. & Esteban, M. (2010). Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions. PLoS ONE 5, e12395.
6. Gómez, C. E., Ná jera, J. L., Jimé nez, E. P., Jimé nez, V., Wagner, R., Graf, M., Frachette, M. J., Liljeströ m, P., Pantaleo, G. & Esteban, M. (2007a). Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B. Vaccine 25, 2863-2885.
7. Gómez, C. E., Ná jera, J. L., Jimé nez, V., Bieler, K., Wild, J., Kostic, L., Heidari, S., Chen, M., Frachette, M. J. & other authors (2007b). Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C. Vaccine 25, 1969-1992.
8. Gómez, C. E., Perdiguero, B., Garcia-Arriaza, J. & Esteban, M. (2012a). Poxvirus vectors as HIV/AIDS vaccines in humans. Hum Vaccin Immunother 8, 1192-1207.
9. Gómez, C. E., Perdiguero, B., Jimé nez, V., Filali-Mouhim, A., Ghneim, K., Haddad, E. K., Quakkelaar, E. D., Delaloye, J., Harari, A. & other authors (2012b). Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C. PLoS ONE 7, e35485.
10. Good, M. F. & Doolan, D. L. (2010). Malaria vaccine design: immunological considerations. Immunity 33, 555-566.
11. Honess, R. W. & Roizman, B. (1975). Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A 72, 1276-1280.
12. Kastenmuller, W., Gasteiger, G., Gronau, J. H., Baier, R., Ljapoci, R., Busch, D. H. & Drexler, I. (2007). Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med 204, 2187-2198.
13. Moutaftsi, M., Salek-Ardakani, S., Croft, M., Peters, B., Sidney, J., Grey, H. & Sette, A. (2009). Correlates of protection efficacy induced by vaccinia virus-specific CD8+ T-cell epitopes in the murine intranasal challenge model. Eur J Immunol 39, 717-722.
14. Orubu, T., Alharbi, N. K., Lambe, T., Gilbert, S. C. & Cottingham, M. G. (2012). Expression and cellular immunogenicity of a transgenic antigen driven by endogenous poxviral early promoters at their authentic loci in MVA. PLoS ONE 7, e40167.
15. Pasquetto, V., Bui, H. H., Giannino, R., Banh, C., Mirza, F., Sidney, J., Oseroff, C., Tscharke, D. C., Irvine, K. & other authors (2005). HLAA* 0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol 175, 5504-5515.
16. Ramírez, J. C., Gherardi, M. M. & Esteban, M. (2000). Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B-and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine. J Virol 74, 923-933.
17. Ross, L. & Guarino, L. A. (1997). Cycloheximide inhibition of delayed early gene expression in baculovirus-infected cells. Virology 232, 105-113.
18. Salser, W., Bolle, A. & Epstein, R. (1970). Transcription during bacteriophage T4 development: a demonstration that distinct subclasses of the early RNA appear at different times and that some are turned off at late times. J Mol Biol 49, 271-295.
19. Sánchez-Sampedro, L., Gómez, C. E., Mejías-Pé rez, E., Sorzano, C. O. S. & Esteban, M. (2012). High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infection. PLoS ONE 7, e38859.
20. Sette, A., Grey, H., Oseroff, C., Peters, B., Moutaftsi, M., Crotty, S., Assarsson, E., Greenbaum, J., Kim, Y. & other authors (2009). Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens. Vaccine 27 (Suppl 6), G21-G26.
21. Vijayan, A., Gómez, C. E., Espinosa, D. A., Goodman, A. G., Sanchez-Sampedro, L., Sorzano, C. O., Zavala, F. & Esteban, M. (2012). Adjuvant-like effect of vaccinia virus 14K protein: a case study with malaria vaccine based on the circumsporozoite protein. J Immunol 188, 6407-6417.
22. Wilson, E. H. & Hunter, C. A. (2008). Immunodominance and recognition of intracellular pathogens. J Infect Dis 198, 1579-1581.
23. Yang, Z., Bruno, D. P., Martens, C. A., Porcella, S. F. & Moss, B. (2010). Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencing. Proc Natl Acad Sci U S A 107, 11513-11518.
24. Yusim, K., Dilan, R., Borducchi, E., Stanley, K., Giorgi, E., Fischer, W., Theiler, J., Marcotrigiano, J., Korber, B. & Barouch, D. H. (2013). Hepatitis C genotype 1 mosaic vaccines are immunogenic in mice and induce stronger T-cell responses than natural strains. Clin Vaccine Immunol 20, 302-305.